陕西省47种药品的价格和可获得性研究  

Study on Prices and Availability of 47 Kinds of Drugs in Shaanxi Province

作　　者：闫抗抗[1] 杨世民[1] 方宇[1] 赵君[1] 刘均[1] 

机构地区：[1]西安交通大学医学院药学系,西安710061

出　　处：《中国药房》2013年第12期1072-1075,共4页China Pharmacy

基　　金：国家自然科学基金资助项目(No.71103141/G0308);陕西省社会科学基金资助项目(No.10E066);中央高校基本科研业务费专项资金资助项目(No.2011jdhz62)

摘　　要：目的:了解药品在陕西省公立医疗卫生机构和零售药店的可获得性,研究陕西省药品价格与国际参考价格的差异。方法:采用世界卫生组织/国际卫生行动组织(WHO/HAI)药品价格标准化调查方法(2008版),于2010年9月对陕西省50所公立医院、36家零售药店47种药品的原研药和最低价格仿制药的价格和可获得性进行调查。结果与结论:调查的47种药品中,公立医院原研药的可获得性很低;公立医院药品的采购价格高于国际参考价;公立医院原研药的零售价格远高于国际参考价,最低价格仿制药价格略低于国际参考价,药品加成率与国家有关规定有出入。政府应提高成本核算技术,药品定价时需与国际参考价格对比,保证价格的制定与国际参考价格具有可比性。应建立政府定价和市场价格监督机制,完善药品价格监控,建立并强化药品定价失真的问责机制,同时,规范药品集中招标采购。OBJECTIVE： To analyze the availability of drugs in public hospital and retail pharmacy in Shaanxi province, and to study the difference between medicine price of Shaanxi province and international reference prices. METHODS： By using WHO-HAl standard medicine price survey methods （2008 edition）, the price and availability of 47 kinds of original drugs and lowest priced generic drugs were investigated in 50 public hospitals and 36 retail pharmacies in Sep. 2010. RESULTS ＆ CONCLUSIONS： These 47 kinds of drugs in Shaanxi province, the availability of originator brand in public hospital is very low; procurement price of medicines in public hospitals is higher than international reference price; sale price of originator brand in public hospitals is far higher than international reference price, the lowest priced generic drugs is slightly lower than international reference price, and the rate of price addition had significant differences according to national regulation. Suggestions： the government improves the cost-accounting techniques, and compares drug price with international reference price when pricing; it is guaranteed that price is comparable to international reference prices. It is suggested to establish a government pricing and market price monitoring mechanism, improving the methods of drug price monitoring, build and strengthen accountability mechanisms for drug pricing distortions, and specify drug centralized bid procurement in the same time.

关 键 词：药品价格 可获得性 陕西省 

分 类 号：R195[医药卫生—卫生统计学]